NEW YORK, Dec. 18, 2017 /PRNewswire/ — Neurotrope, Inc. (NASDAQ: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzheimer’s disease (AD), today announced the appointment of Charles S. Ryan, JD, PhD as Chief Executive…
